1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. GENFIT
  6. News
  7. Summary
    GNFT   FR0004163111

GENFIT

(GNFT)
  Report
Real-time Euronext Paris  -  05/27 11:35:24 am EDT
3.320 EUR   +2.15%
05/26GENFIT, May 25, 2022 Combined Shareholders Meeting results
AQ
05/26GENFIT : May 25, 2022 Combined Shareholders Meeting results - Form 6-K
PU
05/25GENFIT : May 25, 2022 Combined Shareholders Meeting results
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European ADRs Move Lower in Monday Trading

01/10/2022 | 11:05am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AMARIN CORPORATION PLC 0.70% 1.44 Delayed Quote.-57.27%
ASML HOLDING N.V. 4.70% 541.3 Real-time Quote.-23.40%
BHP GROUP LIMITED 2.46% 43.67 Delayed Quote.2.70%
CALLIDITAS THERAPEUTICS AB (PUBL) 4.58% 89 Delayed Quote.-24.56%
CARNIVAL CORPORATION 5.75% 13.97 Delayed Quote.-34.34%
GENFIT 2.15% 3.32 Real-time Quote.-23.08%
GRIFOLS, S.A. -0.23% 19.85 Delayed Quote.17.63%
HSBC HOLDINGS PLC 1.35% 532.4 Delayed Quote.18.67%
IDEX BIOMETRICS ASA 0.81% 1.24 Real-time Quote.-61.08%
IDEX CORPORATION 1.60% 192.14 Delayed Quote.-18.70%
MEREO BIOPHARMA GROUP PLC 8.77% 0.521 Delayed Quote.-67.44%
MORPHOSYS AG 0.65% 20.16 Delayed Quote.-39.55%
MYT NETHERLANDS PARENT B.V. 2.28% 11.66 Delayed Quote.-45.03%
NATUZZI S.P.A. 8.57% 10.39 Delayed Quote.-34.78%
TELEFÓNICA, S.A. -0.10% 4.947 Delayed Quote.28.43%
TRINITY BIOTECH PLC 0.00% 1.38 Delayed Quote.-3.50%
VODAFONE GROUP PLC -0.97% 130.14 Delayed Quote.15.93%
All news about GENFIT
05/26GENFIT, May 25, 2022 Combined Shareholders Meeting results
AQ
05/26GENFIT : May 25, 2022 Combined Shareholders Meeting results - Form 6-K
PU
05/25GENFIT : May 25, 2022 Combined Shareholders Meeting results
GL
05/25GENFIT : May 25, 2022 Combined Shareholders Meeting results
AQ
05/25GENFIT : Proxy Statments
CO
05/13European ADRs Move Higher in Friday Trading
MT
05/12European ADRs Decline in Thursday Trading
MT
05/11GENFIT Reports First Quarter 2022 Financial Information (Unaudited financial informatio..
GL
05/11GENFIT Reports First Quarter 2022 Financial Information (Unaudited financial informatio..
AQ
05/11GENFIT Reports Unaudited Revenue Results for the First Quarter Ended March 31, 2022
CI
More news
Analyst Recommendations on GENFIT
More recommendations
Financials
Sales 2022 29,0 M 31,1 M 31,1 M
Net income 2022 -49,5 M -53,0 M -53,0 M
Net cash 2022 150 M 160 M 160 M
P/E ratio 2022 -4,65x
Yield 2022 -
Capitalization 165 M 177 M 177 M
EV / Sales 2022 0,53x
EV / Sales 2023 3,04x
Nbr of Employees 122
Free-Float 86,8%
Chart GENFIT
Duration : Period :
GENFIT Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENFIT
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 3,32 €
Average target price 10,48 €
Spread / Average Target 216%
EPS Revisions
Managers and Directors
Pascal Prigent CEO & EVP-Marketing & Development
Thomas Baetz Chief Financial Officer
Jean-François Mouney Chairman
Dean W. Hum Chief Scientific Officer
Carol L. Addy Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
GENFIT-23.08%177
MODERNA, INC.-41.86%54 016
LONZA GROUP AG-28.07%42 292
IQVIA HOLDINGS INC.-21.85%39 319
SEAGEN INC.-8.54%25 487
ICON PUBLIC LIMITED COMPANY-26.61%17 693